Please login to the form below

King Pharmaceuticals

This page shows the latest King Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

The company secured rights to Troxyca ER (also known as ALO-02) when it acquired King Pharmaceuticals in 2010 for $3.6bn.

Opioid analgesics

The initial development of this immediate-release tamper-resistant formulation, formally known as Acurox, was under collaboration with Acura and King Pharmaceuticals. ... As part of the research programme initiated by King Pharmaceuticals (now Pfizer)
Burton Paul appointed to 1HQ’s health division

Paul brings more than 15 years experience in managing projects and clients across a wide range of sectors including FMCG and pharmaceuticals. ... His work includes brand delivery for some of the biggest names in the sector, most notably: Adcock Ingram,
Lipitor losses affect Pfizer's Q2 sales

Sales were aided by the purchase of King Pharmaceuticals, with Pfizer gaining an extra $357m in sales.
FDA approves Pfizer's pain drug

Oxecta was originally developed by King Pharmaceuticals. Pfizer acquired the drug when it purchased King in late 2010.
Survival strategy

Marketed products. The M&A strategy in 2010 was reflected in Pfizer's acquisition of King Pharmaceuticals for $3.6bn announced in October and Astellas' acquisition of OSI Pharmaceuticals for $4bn ... Nevertheless there were a few deals in 2010, such as

More from news
Approximately 0 fully matching, plus 21 partially matching documents found.

GW hires Pfizer’s Kenneth Sommerville

Dr Sommerville was VP, clinical sciences, at Pfizer for three years having joined the company from King Pharmaceuticals.
ParagonRx appoints ex-FDA medical officer

He was promoted to senior director of medical affairs and then after King Pharmaceuticals' acquisition of Alpharma, Dr Sun served as King's senior director of pharmacovigilance and risk management.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Add my company

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...